What is ABVD Chemotherapy treatment for Hodgkin’s Lymphoma?
Hodgkin’s Lymphoma is a type of cancer affecting the White Blood Cells (WBC), which are an integral part of the body’s immune system. “ABVD” stands for the chemotherapy drug treatment regimen which is frequently used for the treatment of Hodgkin’s disease. This regimen is used for the treatment of patients in the early stages of Hodgkin’s Lymphoma. It is comparatively less toxic and doesn’t result in major bone marrow suppression, like the other stronger and high- dosage chemotherapy regimens. What does ABVD chemotherapy treatment regimen include? ABVD chemotherapy comprises of four, (to a maximum of eight cycles) of drugs given intravenously, with each cycle lasting for four weeks. The number of cycles depends upon the stage of Hodgkin’s Lymphoma. The treatment is done on an out patient basis and doesn’t require hospitalization; unless the patient’s medical condition is critical. The regimen comprises of four drugs Adriamycin (A), Blenoxane (B), Velban (V) and Dacarbazine (D), which h
